World's Best Scientists 2026 revealed!
Journal of Cystic Fibrosis
H-index 41

Journal of Cystic Fibrosis

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 516 279 761 34

Additional Metrics

Number of Best Scientists*: 859
Documents by Best Scientists*: 1828
Top 100 Ranked Scientists*: 29
SCIMAGO H-index: 98
SCIMAGO SJR: 1.772
Impact Factor: 6

Overview

Top Research Topics at Journal of Cystic Fibrosis?

Journal of Cystic Fibrosis tackles a plethora of topics, such as Cystic fibrosis, Internal medicine, Gastroenterology, Pediatrics and Microbiology. The work on Cystic fibrosis tackled in Journal of Cystic Fibrosis brings together disciplines like Pseudomonas aeruginosa, Intensive care medicine, Immunology and Pathology. It focuses on Internal medicine but the discussions also offer insight into other areas such as Endocrinology, Surgery and Sputum.

It centers on topics in Pediatrics, with a focus on Newborn screening.

  • Cystic fibrosis (88.44%)
  • Internal medicine (30.85%)
  • Gastroenterology (14.88%)

What are the most cited papers published in the journal?

  • Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients (461 citations)
  • Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice (444 citations)
  • Standards of care for patients with cystic fibrosis: a European consensus (387 citations)

Research areas of the most cited articles at Journal of Cystic Fibrosis:

The journal articles primarily tackle Cystic fibrosis, Internal medicine, Immunology, Gastroenterology and Pseudomonas aeruginosa. Cystic fibrosis research presented in the published articles is mostly focused on the subject of Cystic fibrosis transmembrane conductance regulator. The journal publications explore issues in Internal medicine which can be linked to other research areas like Endocrinology and Sputum.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

The journal is mainly concerned with subjects like Cystic fibrosis, Internal medicine, Gastroenterology, Pediatrics and Microbiology. Cystic fibrosis research presented is mostly focused on the subject of Ivacaftor. Tezacaftor and Lumacaftor studies are all carried out as a component of the study in Ivacaftor presented.

The journal tackles research in Cystic fibrosis-related diabetes, Cohort and Lung function as part of the general discipline of Internal medicine, however, it also discusses concepts in In patient. The work on Coronavirus disease 2019 (COVID-19) presented in it focuses on Pandemic in particular. The journal features 2019-20 coronavirus outbreak research that overlaps with concepts in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The most cited articles from the last journal are:

  • Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants (15 citations)
  • A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation (14 citations)
  • Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study. (13 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Cystic Fibrosis (based on the number of publications) are:

  • M.J. Walshaw (200 papers) published 14 papers at the last edition, 1 more than at the previous edition,
  • Joseph Elborn (194 papers) published 2 papers at the last edition, 6 less than at the previous edition,
  • Daniel Peckham (176 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Andrew M. Jones (137 papers) published 9 papers at the last edition, 6 less than at the previous edition,
  • K. De Boeck (136 papers) published 3 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Cystic Fibrosis (based on the number of publications) are:

  • Boston Children's Hospital (299 papers) published 36 papers at the last edition, 3 more than at the previous edition,
  • University of Toronto (111 papers) published 18 papers at the last edition, 8 more than at the previous edition,
  • Katholieke Universiteit Leuven (108 papers) published 7 papers at the last edition, 3 less than at the previous edition,
  • University of Washington (104 papers) published 22 papers at the last edition, 8 more than at the previous edition,
  • Queen's University Belfast (103 papers) published 13 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 80.29% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 38.91% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.28% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.95% of all publications and 33.85% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Research: A Spotlight on Nurse Practitioners

Another interesting facet of medical research – and one that's integral to the practical implementation of the research findings – are the healthcare professionals who work on the front lines. One such group that contributes significantly to healthcare research are nurse practitioners. This includes those who specialize in fields such as pediatrics and internal medicine, both areas of focus in the Journal of Cystic Fibrosis. Nurse practitioners bridge the gap between research and patient care, utilizing the latest findings to improve the quality of life of their patients. As they deepen their expertise, many nurse practitioners also become involved in clinical research, jointly authoring academic papers and even leading research projects. Particularly in locations like Arkansas, the immense value provided by nurse practitioners has highlighted an increased demand and subsequent opportunities for growth in this career path. If you're considering pursuing this rewarding career, understanding the nurse practitioner program requirements arkansas can give you a clear picture of the educational and licensing path to becoming a nurse practitioner in Arkansas. By merging direct patient care with the ability to influence healthcare research, nurse practitioners indeed have a unique and impactful role in the healthcare system. Whether in the realm of Cystic Fibrosis or other medical specialties, their contributions epitomize the fusion of research and healthcare delivery.

Top Publications

  • Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

    Nataliya Volkova;Kristin Moy;Jennifer Evans;Daniel Campbell

    (2020)
    216 Citations
  • Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease.

    Siddhartha G. Kapnadak;Emily Dimango;Denis Hadjiliadis;Sarah E. Hempstead

    (2020)
    135 Citations
  • A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.

    Rebecca Cosgriff;Susannah Ahern;Scott C. Bell;Keith Brownlee

    (2020)
    127 Citations
  • Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.

    (2022)
    113 Citations
  • Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.

    (2022)
    112 Citations
  • Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis.

    (2022)
    90 Citations
  • The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.

    Elliot McClenaghan;Rebecca Cosgriff;Keith Brownlee;Susannah Ahern

    (2020)
    76 Citations
  • Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.

    (2020)
    74 Citations
  • Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis

    Tasma Harindhanavudhi;Qi Wang;Jordan Dunitz;Antoinette Moran

    (2020)
    66 Citations
  • Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.

    Robert Bain;Rebecca Cosgriff;Marco Zampoli;Alexander Elbert

    (2021)
    62 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine, exploring related fields can open up diverse career opportunities. Many students with a background in life sciences consider degrees that build on their biology knowledge. The list of highest paying jobs with biology degree highlights lucrative options beyond traditional medicine, including research, pharmaceuticals, and healthcare technology.

Another promising avenue is medical coding and billing, which plays a critical role in healthcare management. Becoming a medical coder involves specialized training to accurately translate medical procedures into codes for billing and record-keeping. This field offers a stable income and remote work possibilities.

Choosing the right credentials is essential. Understanding the differences between certifications, such as CPC vs CCS, can impact career growth and salary. A detailed comparison of certified professional coder certifications provides insights into cost, benefits, and job prospects.

While the medical billing and coding outlook remains positive, it’s important to weigh both advantages and challenges in this career. For students exploring medicine, these related pathways can offer rewarding alternatives or complementary skills to thrive in healthcare.

Best Scientists Contributing to This Journal